{"id":9256,"date":"2022-05-10T01:00:00","date_gmt":"2022-05-10T01:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/3750472_CN50472_0"},"modified":"2022-05-10T01:00:00","modified_gmt":"2022-05-10T01:00:00","slug":"affamed-therapeutics-holds-dextenza-launch-and-advisory-board-meeting-in-macau","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=9256","title":{"rendered":"AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau"},"content":{"rendered":"<p><span class=\"legendSpanClass\"><span class=\"xn-location\">SHANGHAI<\/span>, May 10, 2022 \/PRNewswire\/ &#8212;&nbsp;AffaMed Therapeutics (&#8220;AffaMed&#8221;), a global clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products, held a DEXTENZA Launch and Advisory Board Meeting recently in <span class=\"xn-location\">Macau<\/span>, following DEXTENZA&#8217;s approval for the treatment of post-surgical&nbsp;ocular pain&nbsp;and&nbsp;inflammation. Dr. <span class=\"xn-person\">Iat Fan Lai<\/span> from Kiang Wu Hospital, Dr. <span class=\"xn-person\">John Hovanesian<\/span> from Harvard Eye Association, Dr. <span class=\"xn-person\">Alice Epitropoulos<\/span> from The Eye Center of Columbus, and 21 surgeons from <span class=\"xn-location\">Macau<\/span> and <span class=\"xn-location\">Hong Kong<\/span> attended the meeting in person or virtually.<\/span><\/p>\n<p>The meeting was held to facilitate academic and clinical communication, share the patient benefit of DEXTENZA, and collect insights from the healthcare practitioners in <span class=\"xn-location\">Macau<\/span> and <span class=\"xn-location\">Hong Kong<\/span> on post-surgical&nbsp;ocular pain&nbsp;and&nbsp;inflammation. The meeting&#8217;s topics covered corticosteroid clinical application in <span class=\"xn-location\">Macau<\/span> and unmet clinical needs, the introduction of DEXTENZA&#8217;s clinical benefits, DEXTENZA clinical experience sharing, and academic discussion.<\/p>\n<p>Dr. <span class=\"xn-person\">Dayao Zhao<\/span>, CEO of AffaMed joined the meeting online and commented: &#8220;DEXTENZA has made significant advances in Mainland China and <span class=\"xn-location\">Macau<\/span>. We are excited to launch the product, and we look forward to working with the experts to bring this preservative-free and noninvasive treatment option to patients suffering post-surgical&nbsp;ocular pain&nbsp;and&nbsp;inflammation in <span class=\"xn-location\">Macau<\/span>.&#8221;<\/p>\n<p>Dr. <span class=\"xn-person\">Iat Fan Lai<\/span> from Kiang Wu Hospital, <span class=\"xn-location\">Macau<\/span> said: &#8220;The launch of DEXTENZA in <span class=\"xn-location\">Macau<\/span> is exciting news for us. Its innovative hydrogel technology will reduce the drug burden of patients and improve treatment experience and convenience. And knowledge sharing from <span class=\"xn-location\">USA<\/span> KOLs is very precious, helping us have a comprehensive understanding about current DEXTENZA clinical practice and operation tips.&#8221;<\/p>\n<p>Dr. <span class=\"xn-person\">John Hovanesian<\/span> from Harvard Eye Association said: &#8220;I&#8217;m thrilled to be part of the launch of this innovative technology with our colleagues in <span class=\"xn-location\">Macau<\/span>. Sustained drug delivery gives patients convenience and surgeon&#8217;s confidence with a proven safe platform.&#8221;<\/p>\n<p>Dr. <span class=\"xn-person\">Alice Epitropoulos<\/span> from The Eye Center of Columbus said: &#8220;DEXTENZA is a major step forward in steroid treatment with improved compliance and a healthier ocular surface. I am excited for surgeons &amp; patients in <span class=\"xn-location\">Macau<\/span> who will now also have access to this advancement in drug delivery.&#8221;<\/p>\n<p>In 2020, AffaMed Therapeutics entered into a licensing agreement with Ocular Therapeutix (NASDAQ: OCUL) for the development and commercialization of DEXTENZA in <span class=\"xn-location\">Greater China<\/span>, <span class=\"xn-location\">South Korea<\/span>, and certain ASEAN markets. DEXTENZA is currently approved in the U.S. for the treatment of ocular inflammation and pain following ophthalmic surgery and for the treatment of ocular itching associated with allergic conjunctivitis.<\/p>\n<p><b>About AffaMed Therapeutics<\/b><\/p>\n<p>AffaMed Therapeutics is a clinical stage biopharmaceutical company focused on developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmological, neurological and&nbsp;psychiatric&nbsp;disorders&nbsp;for patients in <span class=\"xn-location\">Greater China<\/span> and around the world. The leadership team at AffaMed Therapeutics has gained deep industry expertise and an extensive track record in high-quality discovery, clinical development, regulatory affairs, business development, manufacturing, and commercial operations at leading multi-national biopharmaceutical companies in <span class=\"xn-location\">China<\/span> and globally.<\/p>\n<p><b>About DEXTENZA<\/b><\/p>\n<p>DEXTENZA is approved for the treatment of post-surgical&nbsp;ocular pain&nbsp;and&nbsp;inflammation in <span class=\"xn-location\">Macau<\/span>. Previously, DEXTENZA is approved in US for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular itching associated with allergic conjunctivitis. DEXTENZA is a corticosteroid intracanalicular insert placed in the punctum, a natural opening in the inner portion of the lower eyelid, and into the canaliculus and is designed to deliver dexamethasone to the ocular surface for up to 30 days without preservatives. DEXTENZA resorbs and exits the nasolacrimal system without the need for removal.<\/p>\n<p id=\"PURL\"><img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN50472&amp;sd=2022-05-09\"> View original content:<a id=\"PRNURL\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/affamed-therapeutics-holds-dextenza-launch-and-advisory-board-meeting-in-macau-301543172.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/affamed-therapeutics-holds-dextenza-launch-and-advisory-board-meeting-in-macau-301543172.html<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SHANGHAI, May 10, 2022 \/PRNewswire\/ &#8212;&nbsp;AffaMed Therapeutics (&#8220;AffaMed&#8221;), a global clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products, held a DEXTENZA Launch and Advisory Board Meeting recently in Macau, following DEXTENZA&#8217;s approval for the treatment of post-surgical&nbsp;ocular pain&nbsp;and&nbsp;inflammation. Dr. Iat Fan Lai from Kiang Wu Hospital, Dr. John Hovanesian [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":9257,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-9256","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=9256\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau - My Blog\" \/>\n<meta property=\"og:description\" content=\"SHANGHAI, May 10, 2022 \/PRNewswire\/ &#8212;&nbsp;AffaMed Therapeutics (&#8220;AffaMed&#8221;), a global clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products, held a DEXTENZA Launch and Advisory Board Meeting recently in Macau, following DEXTENZA&#8217;s approval for the treatment of post-surgical&nbsp;ocular pain&nbsp;and&nbsp;inflammation. Dr. Iat Fan Lai from Kiang Wu Hospital, Dr. John Hovanesian [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=9256\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-10T01:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/05\/affamed-therapeutics-holds-dextenza-launch-and-advisory-board-meeting-in-macau.png\" \/>\n\t<meta property=\"og:image:width\" content=\"16\" \/>\n\t<meta property=\"og:image:height\" content=\"16\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9256#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9256\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau\",\"datePublished\":\"2022-05-10T01:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9256\"},\"wordCount\":618,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9256#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/affamed-therapeutics-holds-dextenza-launch-and-advisory-board-meeting-in-macau.png\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9256\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9256\",\"name\":\"AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9256#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9256#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/affamed-therapeutics-holds-dextenza-launch-and-advisory-board-meeting-in-macau.png\",\"datePublished\":\"2022-05-10T01:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9256#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9256\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9256#primaryimage\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/affamed-therapeutics-holds-dextenza-launch-and-advisory-board-meeting-in-macau.png\",\"contentUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/affamed-therapeutics-holds-dextenza-launch-and-advisory-board-meeting-in-macau.png\",\"width\":16,\"height\":16},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9256#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=9256","og_locale":"en_US","og_type":"article","og_title":"AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau - My Blog","og_description":"SHANGHAI, May 10, 2022 \/PRNewswire\/ &#8212;&nbsp;AffaMed Therapeutics (&#8220;AffaMed&#8221;), a global clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products, held a DEXTENZA Launch and Advisory Board Meeting recently in Macau, following DEXTENZA&#8217;s approval for the treatment of post-surgical&nbsp;ocular pain&nbsp;and&nbsp;inflammation. Dr. Iat Fan Lai from Kiang Wu Hospital, Dr. John Hovanesian [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=9256","og_site_name":"My Blog","article_published_time":"2022-05-10T01:00:00+00:00","og_image":[{"width":16,"height":16,"url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/05\/affamed-therapeutics-holds-dextenza-launch-and-advisory-board-meeting-in-macau.png","type":"image\/png"}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=9256#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=9256"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau","datePublished":"2022-05-10T01:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=9256"},"wordCount":618,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=9256#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/05\/affamed-therapeutics-holds-dextenza-launch-and-advisory-board-meeting-in-macau.png","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=9256","url":"https:\/\/transmediavictoria.net.au\/?p=9256","name":"AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=9256#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=9256#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/05\/affamed-therapeutics-holds-dextenza-launch-and-advisory-board-meeting-in-macau.png","datePublished":"2022-05-10T01:00:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=9256#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=9256"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=9256#primaryimage","url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/05\/affamed-therapeutics-holds-dextenza-launch-and-advisory-board-meeting-in-macau.png","contentUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/05\/affamed-therapeutics-holds-dextenza-launch-and-advisory-board-meeting-in-macau.png","width":16,"height":16},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=9256#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/9256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9256"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/9256\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/media\/9257"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9256"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9256"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}